Palisade Bio (PALI) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -66.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.74% |
| Dec 31, 2025 | -32.05% |
| Sep 30, 2025 | -13.41% |
| Jun 30, 2025 | 48.07% |
| Mar 31, 2025 | 26.64% |
| Dec 31, 2024 | 13.29% |
| Sep 30, 2024 | -17.69% |
| Jun 30, 2024 | -59.12% |
| Mar 31, 2024 | 9.81% |
| Dec 31, 2023 | 17.19% |
| Sep 30, 2023 | 12.43% |
| Jun 30, 2023 | 32.34% |
| Mar 31, 2023 | 6.32% |
| Dec 31, 2022 | -8.54% |
| Sep 30, 2022 | -10.71% |
| Jun 30, 2022 | 57.91% |
| Mar 31, 2022 | -201.12% |
| Dec 31, 2021 | -97.22% |
| Sep 30, 2021 | -216.36% |
| Jun 30, 2021 | -1,046.77% |
| Mar 31, 2021 | 25.49% |
| Dec 31, 2020 | 24.40% |
| Sep 30, 2020 | 54.25% |
| Jun 30, 2020 | 59.03% |
| Mar 31, 2020 | -0.70% |
| Dec 31, 2019 | -23.58% |
| Sep 30, 2019 | -14.02% |
| Jun 30, 2019 | 34.87% |
| Mar 31, 2019 | 9.80% |
| Dec 31, 2018 | 27.49% |
| Sep 30, 2018 | 49.94% |
| Jun 30, 2018 | 25.15% |
| Mar 31, 2018 | 58.36% |
| Dec 31, 2017 | 43.96% |
| Sep 30, 2017 | 25.73% |
| Jun 30, 2017 | 7.77% |
| Mar 31, 2017 | -26.64% |
| Dec 31, 2016 | -3.37% |
| Sep 30, 2016 | 19.21% |
| Jun 30, 2016 | 25.17% |
| Mar 31, 2016 | 26.04% |
| Dec 31, 2015 | -12.27% |
| Sep 30, 2015 | -77.09% |
| Jun 30, 2015 | -99.68% |
| Mar 31, 2015 | -67.71% |
| Dec 31, 2014 | -41.64% |
| Sep 30, 2014 | -32.74% |
| Jun 30, 2014 | 27.27% |
| Mar 31, 2014 | -12.31% |
| Dec 31, 2013 | 1.78% |
| Sep 30, 2013 | -65.89% |
| Jun 30, 2013 | -36.26% |
| Mar 31, 2013 | -19.70% |
| Dec 31, 2012 | -41.03% |
| Sep 30, 2012 | 21.90% |
| Jun 30, 2012 | -5.33% |
| Mar 31, 2012 | 10.18% |
| Dec 31, 2011 | 35.95% |
| Sep 30, 2011 | 22.74% |